跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Raben - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Raben
Approved
STANDARD
Raben
Endurance HealthCare Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
378f660c5c30d776
Company
Endurance HealthCare Ltd.
Type
Standard
Approval Details
Approval Id
378f660c5c30d776
Drug Approval Philippines Name
Raben
Product Name
Raben
Registration Number
DRP-6050
Brand Name
Raben
Generic Name
Rabeprazole Sodium
Dosage Form
Lyophilized Powder For Injection (Iv)
Dosage Strength
20mg
Manufacturer
Endurance HealthCare Ltd.
Importer
Ambica International Trading Corp.
Distributor
Ambica International Trading Corp.
Issuance Date
24 April 2024
Expiry Date
25 March 2030
Pharmacologic Category
Proton Pump Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
378f660c5c30d776
Type
Standard
Back to Philippines FDA Approvals